老虎证券

BRIEF-Infinity Pharmaceuticals Announces Termination Of Merger Agreement With MEI Pharma

Reuters
2023/07/24

July 24 (Reuters) - Infinity Pharmaceuticals Inc

:

* INFINITY PHARMACEUTICALS ANNOUNCES TERMINATION OF MERGER AGREEMENT WITH MEI PHARMA

* INFINITY PHARMACEUTICALS INC- EGANELISIB REMAINS PRIMARY VALUE DRIVER FOR INFINITY

* INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS

* INFINITY PHARMACEUTICALS INC - INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS

* INFINITY PHARMACEUTICALS INC- INFINITY TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE FOR STOCKHOLDERS

* INFINITY PHARMACEUTICALS - COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES

* INFINITY PHARMACEUTICALS INC- AS A RESULT OF TERMINATION OF MERGER AGREEMENT, INFINITY ENTITLED TO REIMBURSEMENT OF OF $1 MILLION FROM MEI

* INFINITY PHARMACEUTICALS INC - INFINITY HAS POTENTIAL TO RECEIVE AN ADDITIONAL $4 MILLION TERMINATION FEE FROM MEI UNDER CERTAIN CIRCUMSTANCES

* INFINITY PHARMACEUTICALS INC- COMPANY'S BOARD AND MANAGEMENT TEAM EXPECT TO UNDERTAKE A SERIES OF COST SAVING MEASURES

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10